| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |